Introduction {#sec1}
============

Klinefelter syndrome (KS), with a 1:500 to 1:1000 incidence, is the most frequent sex chromosome abnormality in males. It is an X chromosome aneuploidy characterized in 80--90% of the cases by a nonmosaic 47, XXY karyotype, while higher-grade aneuploidies (such as 48, XXXY) and mosaic forms of KS (such as 46, XY/47, XXY) account for the remaining 10--20%. The supernumerary X chromosome can be of either maternal or paternal origin, caused by failures in chromosome disjunction in meiosis I (maternal or paternal), meiosis II (maternal), or, in rare cases, during the first mitotic cell divisions of zygotes (maternal) ([@ref19]; [@ref4]).

The clinical picture of KS is commonly described as a tall stature, gynecomastia, sparse body hair, small and firm testes, and hypogonadism resulting in azoospermia with hyalinization and fibrosis of the seminiferous tubules ([@ref4]). Although the majority of patients with KS have germ cells in their testes before puberty, azoospermia is predominant in adulthood, making infertility the most common cause for KS diagnosis ([@ref19]; [@ref46]; [@ref33]; [@ref4]; [@ref15]). However, a broad phenotypic spectrum has been described for KS, including higher risk for metabolic disorders, osteoporosis, breast cancer, and autoimmune diseases, as well as verbal processing and attention deficits ([@ref4]; [@ref15]). The variable clinical phenotype of KS is at least partly influenced by the grade of aneuploidy, mosaicism, and origin of the X chromosome, whereas the relatively mild phenotype is thought to result from X chromosome inactivation (XCI), which is a mechanism by which one of the two X chromosomes normally in female somatic cells is transcriptionally silenced to equalize the dosage of X-linked genes between males and females, resulting in one active (Xa) and one inactive (Xi) X chromosome.

XCI in KS patients has been shown by the presence of the Barr body in buccal smears, which has also been used as a screening test for KS diagnosis ([@ref14]). As further evidence of XCI, KS patients have upregulated expression of X-inactive specific transcript (*XIST*), a long noncoding RNA coating the Xi in *cis*, inducing nuclear reorganization and recruitment of histone-modification complexes, thereby helping the initiation and maintenance of XCI ([@ref42]; [@ref30]; [@ref3]). In addition, several studies have utilized the variable (CAG) n repeat of the X-linked androgen receptor gene and methylation-sensitive HpaII restriction site to show inactivation of one of the alleles in KS patients. This assay has also been used as evidence of skewed XCI (preferential XCI in one X chromosome over the other) in some of the KS cases ([@ref41]). While random XCI leads to a normal genetic mosaic of cells, with half of the cells expressing either one of the X chromosomes, skewed patterns of XCI lead to phenotypic variability in a number of human diseases linked to the X chromosome.

XCI in female cells is incomplete, and at least 23% of X-linked genes 'escape' XCI and are expressed also from the Xi, although at lower levels, resulting in sex biases in gene expression ([@ref40]). On the other hand, pseudoautosomal regions of the X chromosome consistently escape XCI to achieve balanced expression dosage between females and males. Thus, the KS phenotype may be influenced by two active copies or, in the case of X-Y homologous genes, three active copies of XCI escaping genes. In addition, some of the escaping genes show variability between individuals and tissues ([@ref40]), which is likely to introduce phenotypic diversity in KS patients and the severity of impact for certain tissues over others. Most of the molecular studies involving KS patients have used samples from whole blood ([@ref44]; [@ref11]; [@ref48]; [@ref3]), while only a few studies have focused on brain ([@ref45]) or testes ([@ref8], [@ref9]; [@ref47]). For better understanding the pathogenesis of KS, multiple cell types should be analyzed, which are often inaccessible.

Human induced pluripotent stem cells (hiPSCs) can be differentiated into any cell type of the body and thus provide a useful model system to study condition-based effects in early development. In addition, human pluripotent stem cells (hPSCs) have clonal XCI with the same parental X-chromosome inactivated in all cells, which allows a more detailed analysis of XCI from transcriptomics data ([@ref38]; [@ref34]). One study with a KS patient-derived hiPSC line suggested XCI based on H3K27me3 staining (histone tri-methylation of lysine 27 on histone H3) and *XIST* gene expression and, regardless, showed aberrant gene expression of X-linked genes ([@ref21]). However, female hPSCs have at least three XCI states: XaXi with *XIST* coating, XaXi lacking *XIST* coating, and XaXe (partially eroded XCI) ([@ref28]). The state varies not only between cell lines but also between cell passages and even within a cell population; thus, it is important to match the samples when studying the connection of XCI and gene expression.

The present study focuses on the characterization of KS hiPSCs from two azoospermic donors in regards to their XCI state as well as their potential applicability as an *in vitro* KS disease model.

Materials and Methods {#sec2}
=====================

Fibroblast derivation and culture {#sec3}
---------------------------------

Skin punch (4 mm punch) biopsies from the upper lateral quadrant of the gluteal region of healthy male (HM) donors (HM1, 31 years; HM2, 34 years) and azoospermia patients diagnosed with KS (KS1, 31 years; KS2, 34 years) at the Division of Reproductive Medicine at the Karolinska Hospital Huddinge, were obtained with a written informed consent and with the approval of the Stockholm Regional Ethics Board (Dnr: 2013/1132-32). After removing the dermis, tissue was cut into *c.*1 mm^3^ pieces and plated on fetal bovine serum (FBS; Life Technologies, USA) coated plates with human dermal fibroblast (HDF) medium consisting of Dulbecco's Modified Eagle Medium (Life Technologies), 10% FBS, and 1× penicillin--streptomycin (Life Technologies). The resulting fibroblast cultures were passaged with 0.05% Trypsin (Life Technologies). Additional fibroblasts used were human female dermal fibroblasts (f-HF1; 31 years; Lonza, Switzerland).

Reprogramming and culture of hiPSCs and human embryonic stem cells {#sec4}
------------------------------------------------------------------

Reprogramming of fibroblasts with episomal plasmids was performed as previously reported ([@ref27]) with some modifications. Briefly, 6 × 10^5^ cells were electroporated with 1 μg of each plasmid; pCXLE-hOCT3/4-shp53, pCXLE-hSK, and pCXLE-hUL (gift from Dr Shinya Yamanaka), using the 100 μl tip Neon System (Life Technologies) with 1650 V, 30 ms, and 1 pulse settings. Transfected cells were plated onto noncoated cell culture plates with HDF medium for 6 days in 5% CO~2~, at 37°C. Cells were collected using 0.25% Trypsin (Life Technologies) and plated onto 10 μg/ml laminin 521 (LN521; Biolamina, Sweden) coated plates or onto human embryonic stem cell (hESC)-qualified Matrigel (BD Biosciences, USA) coated plates at a density of 5 × 10^3^ cells/cm^2^ and transferred to low oxygen conditions (5% O~2~ and 5% CO~2~) at 37°C. The following day, HDF medium was replaced by Nutristem hPSC XF Medium (Biological Industries, USA) with medium changes every 2--3 days. Cell colonies were manually picked onto LN521 coated plates 23--40 days after transfection and maintained in Nutristem hPSC XF Medium throughout culture. Upon confluency, cells were passaged as single cells using 1× TrypLE Select (Life Technologies). The hESC line HS980, 46,XX ([@ref32]) was used in this study with the approval of the Stockholm Regional Ethics Board (Dnr: 454/02).

Spontaneous *in vitro* differentiation {#sec5}
--------------------------------------

Confluent cell cultures were detached as small cell clumps and plated onto ultra-low adhesion plates (Corning, USA) with Nutristem hPSC XF Medium, GF-free (Biological Industries) containing 10 μM ROCK inhibitor Y-27632 (Millipore, USA) for the first 24 h with subsequent media changes every 2--3 days. After 2 weeks in ultra-low adhesion plates, the embryoid bodies were plated for an additional 2 weeks onto LN521 coated glass chamber slides (Corning). After a total culture of 4 weeks, the cells were fixed with 4% formaldehyde (Sigma-Aldrich, USA).

Teratoma assay {#sec6}
--------------

Confluent cell cultures were detached as small cell clumps and plated onto ultra-low adhesion plates with Nutristem hPSC XF Medium containing 10 μM Y-27632 (Millipore) for 24 h. Sphere suspension was then mixed with hESC-qualified Matrigel and injected s.c. into severely compromised immunodeficient/Beige mice (Taconic, USA) with \~1 × 10^6^ cells/injection. Mice were sacrificed and tumors were collected at 3--8 weeks after injection. Tumors were fixed in 4% formaldehyde and paraffin embedded cross-sections stained for hematoxylin and eosin. Animal work was performed with the approval of Stockholm south ethical committee S14--15.

Quantitative PCR {#sec7}
----------------

For plasmid copy number analysis, genomic DNA (gDNA) was collected using the DNeasy Blood & Tissue kit (Qiagen, Netherlands) according to the manufacturer's protocol. Quantitative PCR (qPCR) analysis was performed with the StepOnePlus Real-Time PCR System (Life Technologies) using SYBR Select Master Mix (Life Technologies). The pCXLE-EGFP plasmid and gDNA from hESCs (H9) were used to generate standard curves to determine the plasmid or gene copy numbers from the threshold cycle values.

Epstein--Barr nuclear antigen 1 (*EBNA-1)* primers (forward: ATC AGG GCC AAG ACA TAG AGA TG; reverse: GCC AAT GCA ACT TGG ACG TT) were used to detect plasmid copies and F-box protein 15 (*FBXO15)* primers (forward: GCC AGG AGG TCT TCG CTG TA; reverse: AAT GCA CGG CTA GGG TCA AA) were used as genomic copy number controls. The cell number in each reaction was determined by dividing the estimated *FBXO15* copy number by two (two alleles in one genome). Approximately 1 × 10^4^ cells were used in one PCR reaction, and results were determined based on at least three reactions.

For gene expression analysis, RNA from three consecutive passages was extracted using the RNeasy Mini Kit (Qiagen) with on-column DNaseI treatment (Qiagen) according to the manufacturer's protocol. qPCR analysis was performed with StepOnePlus Real-Time PCR System (Life Technologies) using Taqman Universal PCR Master Mix (Life Technologies) with Taqman assays (all from Life Technologies) for *glycerinaldehyd-3-phosphate-dehydrogenase (GAPDH*, 4333764F), *Nanog homeobox (NANOG*, Hs02387400_g1), *POU class 5 homeobox 1 (POU5F1*, Hs03005111_g1), SRY-Box 2 (*SOX2*, Hs01053049_s1), growth differentiation factor 3 (GDF3, Hs00220998_m1), and *XIST* (Hs01079824_m1). Relative quantity was determined with 2^-ΔΔCt^, using *GAPDH* as an endogenous control and hESCs (HS980) or f-HF1 as control sample.

Alkaline phosphatase staining and reprogramming efficiency calculation {#sec8}
----------------------------------------------------------------------

For hiPSC colony counting in reprogramming conditions, cells were fixed with 4% formaldehyde for 2 min and washed with 0.05% Tween-20 in Tris-buffered saline (TBS-T; Sigma-Aldrich). Cells were then stained for 15 min using an Alkaline Phosphatase Detection Kit (Millipore) and washed with TBS-T. Positive colonies were counted and imaged with an Olympus IX81. Reprogramming efficiency was calculated by the following formula: number of alkaline phosphatase (AP) positive colonies obtained multiplied by Day 6 plating ratio (total cell count at Day 6/number of cells plated at Day 6) divided by number of cells transfected at Day 0. Statistical significance was tested with unpaired Student's *t*-test using SigmaPlot 13.0 (Systat Software, Inc., USA), significance was accepted at *P* \< 0.05, *n* = 3.

Immunofluorescence staining {#sec9}
---------------------------

For hiPSC characterization, cells were fixed with 4% formaldehyde for 15 min and permeabilized for 10 min with 0.03% Triton X-100 (Sigma-Aldrich) in PBS (Life Technologies). Cells were blocked in PBS containing 10% donkey serum (Jackson ImmunoResearch) and 1% bovine serum albumin (BSA; Sigma-Aldrich) for 1 h and incubated with primary antibodies in blocking buffer at 4°C overnight. After washing, cells were incubated with secondary antibodies in blocking buffer for 1 h and counterstained with 1 μg/ml DAPI (Life Technologies). hiPSCs were imaged with a confocal microscope (LSM700; Zeiss, Germany). Primary antibodies and concentrations used were rabbit a-POU5F1 (0.005 mg/ml; ab19857; Abcam, UK), rabbit a-SOX2 (0.002 mg/ml; ab97959; Abcam), rabbit a-NANOG (0.004 mg/ml; ab21624; Abcam), mouse anti-stage-specific embryonic antigen-4 (a-SSEA4; 0.05 mg/ml; ab16287; Abcam), mouse anti-neuron-specific class III beta-tubulin (a-TUJ1; 0.002 mg/ml; 801201; BioLegend, USA), mouse anti-alpha-smooth muscle actin (a-SMA; ascites 1:500; a2547; Sigma-Aldrich), mouse anti-alpha-fetoprotein (a-AFP; 0.005 mg/ml; ab3980; Abcam), and rabbit a-H3K27me3 (0.0003 mg/ml; ABE44; Millipore). For negative controls mouse IgG (0.4 mg/ml; sc-2025; SantaCruz, USA) and rabbit IgG (1.775 mg/ml; ab172730; Abcam) were used. Secondary antibodies and concentrations used were Alexa Fluor 488 Donkey a-mouse IgG (0.003 mg/ml; 715--546-150; Jackson ImmunoResearch) and Cy3 Donkey a-rabbit IgG (0.0028 mg/ml; 711--166-152; Jackson ImmunoResearch).

Karyotyping {#sec10}
-----------

Cells were treated with 10 μg/ml colcemid (Life Technologies) for 5 h, collected with TrypLE Select and centrifuged. The cell pellet was resuspended in 0.4% potassium chloride solution and incubated for 40 min before fixation with methanol:acetic acid (3:1). The chromosomal G-band analysis was performed at the Genetics Clinic at Skåne University Hospital, Sweden, or at Karolinska University Hospital, Sweden, and at least 20 metaphases were counted.

RNA sequencing sample preparation and data analysis {#sec11}
---------------------------------------------------

RNA was extracted using the RNeasy Mini Kit (Qiagen) with on-column DNase I treatment (Qiagen) according to the manufacturer's protocol from three different passages of f-HM1 (p8--10), f-HM2 (p7, p10--11), f-KS1 (p5, p8--9), f-KS2 (p5, p7--8), f-HF1 (p12--14), ips-HM1 (p13--15), ips-HM2 (p11--13), ips-KS1 (p13--15), ips-KS2 (p11--13), ips-HF1 (p15--17), and HS980 (p23--25). Library preparation and sequencing was performed at the Science for Life Laboratory, Sweden. Briefly, libraries were made using Illumina TruSeq® stranded mRNA with poly-A selection. Total two pools were made from the 33 samples, and each sample pool was sequenced on two lanes using Illumina HiSeq 2500 with 2 × 125 setup.

Initial quality control of generated paired-end reads was performed using the FastQC software. The reference index-based algorithm HISAT 2.1.0 ([@ref16]) was used to align reads with the human reference genome (GRCh37) ([Supplementary Table SI](#sup4){ref-type="supplementary-material"}). The resulting BAM files were examined by MultiQC (version 1.0) ([@ref10]) and then used to estimate transcript abundance (FPKM; fragments per kilobase of exon per million fragments mapped) values using StringTie v1.3.3 ([@ref29]). Pearson product-moment correlation coefficient was calculated to examine closeness among replicates and one replicate (f-HM1 p8) was excluded due to low correlation. Quantified expression values (FPKM) were imported into R (version 3.4.3; R Project), and principal component analysis (PCA) was conducted with the top 10 000 highly expressed genes. Statistical significance for the sum of total X chromosome and autosome expression was tested with one-way ANOVA using SigmaPlot 13.0; significance was accepted at *P* \< 0.05, *n* = 3.

Cuffdiff v2.2.1 ([@ref39]) was used to identify differentially expressed genes (DEGs). The transcripts with a *P*-value \<0.05, fold change ≥1.5, and average FPKM value ≥1 in higher expressing samples were considered to be significantly expressed. The Panther ([@ref24], [@ref23]) online suite of tools was used for overrepresentation test of gene ontology (GO) biological processes with Fisher's exact false discovery rate (FDR) multiple test correction. An FDR \< 0.01 was considered significant.

Sample-specific single nucleotide polymorphisms (SNPs) for chromosome X were identified using the 'mpileup2snp' subcommand of VarScan2 ([@ref17]) with a *P*-value 0.5. Only uniquely mapped reads were considered (*k* = 1). SNP locations with ≥30 reads were considered in downstream analysis. Informative SNPs for each donor were obtained by combining SNPs with ≥5 reads on minor allele in fibroblast replicates and in corresponding hiPSC replicates (f-HM1/ips-HM1: 436; f-HM2/ips-HM2: 368; f-KS1/ips-KS1: 880; f-KS2/ips-KS2: 725; f-HF1/ips-HF1: 920; HS980: 783). SNPs were considered bi-allelic/with variation when 20--80% of reads corresponded to the reference allele, and mono-allelic/no variation when \<20% or \>80% of reads corresponded to the reference allele. Further, only transcripts with all SNPs showing either bi-allelic or mono-allelic status in all replicates were considered informative.

Accession numbers {#sec12}
-----------------

The RNA sequencing data from this publication have been submitted to the Array Express database under the accession number E-MTAB-734.

Single-molecule RNA fluorescence *in situ* hybridization {#sec13}
--------------------------------------------------------

Single-molecule RNA FISH was performed as previously reported ([@ref18]) with minor modifications. Briefly, hiPSCs and fibroblasts cultured on chamber slides (Sarstedt, Germany) were fixed with 4% formaldehyde for 15 min at room temperature and permeabilized with pre-chilled methanol at −20°C for 10 min. After air drying for 30 min, cells were incubated for 10 min at 70°C in Tris--EDTA buffer at pH 8.0 (Ambion, USA), and washed with 2× saline--sodium citrate (SSC) buffer (Ambion). Cells were hybridized with 125 nM Stellaris FISH probes for human XIST with Quasar 570 Dye and human ATRX with Quasar 670 dye (Biosearch Technologies, UK) for 5 h at 38.5°C in hybridization buffer containing 10% deionized formamide (Ambion), 10% dextran sulfate (Sigma), 2 mg/ml tRNA from *Escherichia coli* (Sigma-Aldrich), 2 mM ribonucleoside vanadyl complex (New England Biolabs, USA), and 0.2 mg/ml BSA in 2× SSC (Ambion). Cells were washed three times with wash buffer (20% deionized formamide in 2× SSC buffer) for 15 min at 38.5°C and once with wash buffer containing 1 μg/ml Hoechst 33342 (Molecular Probes, USA) for 15 min at 38.5°C. Cells were mounted with ProLong Diamond Antifade Mountant (Molecular Probes). Image stacks (0.3 μm distance) were acquired using a Nikon Ti-E motorized inverted microscope with a plan Apo λ 60× oil immersion objective (NA = 1.4) and using SpectraX light source (Lumencor, USA) and Andor Zyla 4.2+ sCMOS camera.

Analysis was performed in Fiji ImageJ (ImageJ, USA) on three consecutive passages, counting all cells of four representative images per passage.

DNA fluorescence *in situ* hybridization {#sec14}
----------------------------------------

DNA FISH was performed on the same slides as used for RNA FISH after submerging the slides in PBS for 15 min at 37°C and removing the coverslips. Cells were re-fixed with 4% formaldehyde for 10 min at room temperature and dehydrated in 70%, 90%, and 100% ethanol for 2 min each followed by brief air drying. Cells were treated with 100 μg/ml RNaseA (Qiagen) in PBS for 30 min at 37°C followed by incubation with 10% pepsin (Sigma-Aldrich) in 0.01 M HCl for 5--8 min at 37°C. Cells were then re-fixed for 10 min with 1% formaldehyde and dehydrated in 70%, 90%, and 100% ethanol for 2 min each and air dried. A probe mixture consisting of Vysis CEP X (DXZ1) SpectrumGreen probe, Vysis CEP Y (DYZ1) SpectrumOrange probe and CEP hybridization buffer (all from Abbott Molecular, USA) was applied onto the slide with a coverslip and sealed with Fastik (Staples, USA). The sample plus probes were then co-denaturated for 3 min at 85°C in a heat block followed by overnight hybridization at 41°C in a humidity chamber. Slides were washed with 0.3% Tween-20 in 0.4× SSC for 2 min at 73°C and with 0.1% Tween-20 in 2× SSC for 30 s at room temperature. Cells were counterstained with 1 μg/ml Hoechst 33342 for 10 min and mounted with ProLong Diamond Antifade Mountant. Image stacks (2 μm distance) were acquired using a Nikon Ti-E motorized inverted microscope with a plan Apo λ 60× oil immersion objective (NA = 1.4), a SpectraX light source (Lumencor) and Andor Zyla 4.2+ sCMOS camera. The images were processed and analyzed using ImageJ.

Results {#sec15}
=======

Reprogramming efficiency of HDFs on LN521 and characterization of KS hiPSCs cultured on LN521 {#sec16}
---------------------------------------------------------------------------------------------

For the generation of patient-specific hiPSC lines, dermal fibroblast cultures were established from skin punch biopsies from two KS patients (f-KS1 and f-KS2), two HMs (f-HM1 and f-HM2) and commercially available healthy female fibroblasts (HF; f-HF1). Using human recombinant LN521 as a coating matrix and episomal plasmids pCXLE-hOCT3/4-shp53, pCXLE-hSK, and pCXLE-hUL ([@ref27]) for reprogramming ([Fig. 1A](#f1){ref-type="fig"}) we could observe several small AP positive colonies by Day 15 after transfection. The AP positive colonies were counted and the reprogramming efficiency was calculated to be 0.52% for LN521, which was significantly higher than for Matrigel (0.36%; *P* \< 0.05; [Supplementary Fig. S1A](#sup1){ref-type="supplementary-material"}), which was used as a control.

![**Feeder-free reprogramming conditions with nonintegrating episomal plasmids and characterization of hiPSCs.** (**A**) Overview of reprogramming and characterization schema. (**B**) Chromosomal G-band analysis of at least 25 mitoses confirmed KS karyotype 47,XXY for ips-KS2 cells at passage 20. A representative image is shown. (**C**) Gene expression of pluripotency markers *POU Class 5 Homeobox 1 (POU5F1)*, *Nanog Homeobox* (*NANOG)*, SRY-Box 2 (*SOX2)*, and *Growth Differentiation Factor 3 (GDF3)* for all hiPSC lines was similar to a hESC line (HS980) cultured on laminin 521 (LN521). Mean expression of three biological replicates with ±SD. (**D**) Expression of NANOG, POU5F1, SOX2, and stage-specific embryonic antigen-4 (SSEA4) was confirmed at protein level; ips-KS2 is shown as a representative line. Nuclei were counterstained with DAPI (blue) as shown in the small merged image in the lower right corner; scale bar is equal to 100 μm. (**E**) Three germ-layer formation from ips-KS2. Upper panel shows representative images with cytoskeletal staining of alpha-smooth muscle actin (aSMA, mesoderm) and neuron-specific class III beta-tubulin (TUJ1, ectoderm) as well as alpha fetoprotein (AFP, endoderm) in green with DAPI (blue) as counterstaining. Lower panel shows meso-, endo-, and ectodermal structures of paraffin-embedded teratomas stained with hematoxylin and eosin. Scale bar is equal to 100 μm. See also [Supplementary Figure S1](#sup1){ref-type="supplementary-material"}.](dez134f1){#f1}

The reprogrammed cell colonies were manually picked between 23 and 40 days after transfection and further expanded on LN521 ([Fig. 1A](#f1){ref-type="fig"}). We generated two KS (ips-KS1 and ips-KS2) and two HM (ips-HM1 and ips-HM2), as well as one HF (ips-HF1) hiPSC lines, with each monoclonal derived from a separate donor.

The loss of episomal plasmids for all five hiPSC lines was confirmed at passage 5 by genomic qPCR analysis ([Supplementary Fig. S1B](#sup1){ref-type="supplementary-material"}) and a karyotype of 47,XXY (non-mosaic), 46,XY, or 46,XX confirmed at passage 12 or passage 20 for all five hiPSCs ([Fig. 1B](#f1){ref-type="fig"} and [Supplementary Fig. S1C](#sup1){ref-type="supplementary-material"}; [Supplementary Table SI](#sup4){ref-type="supplementary-material"}). All five hiPSC lines expressed the pluripotency genes *NANOG*, *POU5F1*, *SOX2*, and *GDF3* at similar levels relative to a female hESC line (HS980) cultured on LN521 ([Fig. 1C](#f1){ref-type="fig"}) and showed presence of NANOG, POU5F1, SOX2 ([Fig. 1D](#f1){ref-type="fig"} and [Supplementary Fig. S1D](#sup1){ref-type="supplementary-material"}), and SSEA4 ([Fig. 1D](#f1){ref-type="fig"}) at protein level.

The spontaneous *in vitro* differentiation and teratoma formation assay showed presence of markers representing all three germ layers (AFP for endoderm, aSMA for mesoderm, and TUJ1 for ectoderm) ([Fig. 1E](#f1){ref-type="fig"} and [Supplementary Fig. S1D](#sup1){ref-type="supplementary-material"}) and structures representing all three germ layers ([Fig. 1E](#f1){ref-type="fig"} and [Supplementary Fig. S1D](#sup1){ref-type="supplementary-material"}) in all five hiPSC lines that were reprogrammed and expanded for 20 passages on LN521. Negative controls are shown in [Supplementary Figure S2](#sup2){ref-type="supplementary-material"}.

GO term enrichment shows correlation of KS fibroblasts and hiPSCs with genotype-related clinical features of KS {#sec17}
---------------------------------------------------------------------------------------------------------------

To study KS-specific molecular features, we performed RNA-sequencing for the KS, HM, and HF fibroblasts and hiPSC, as well as for HS980 ([Supplementary Table SII](#sup5){ref-type="supplementary-material"}). PCA showed a separation of fibroblast and hPSC lines along principal component 1, while principal component 2 seemed to separate hPSCs based on karyotype with the exception of ips-HM2 ([Fig. 2A](#f2){ref-type="fig"}). Comparing KS and HM fibroblasts, 311 DEGs could be observed (with fold change of ≥1.5 and *P* \< 0.05), 219 upregulated and 92 downregulated in KS, while only 8 upregulated and 3 downregulated genes were X-linked genes ([Fig. 2B](#f2){ref-type="fig"}; [Supplementary Table SIII](#sup6){ref-type="supplementary-material"}). On the contrary, comparison of KS and HM hiPSC lines showed 920 DEGs, 324 upregulated and 596 downregulated in KS, while 116 upregulated and 2 downregulated genes were X-linked genes ([Fig. 2B](#f2){ref-type="fig"}; [Supplementary Table SIV](#sup7){ref-type="supplementary-material"}).

![**KS fibroblasts and hiPSCs show differentially expressed genes (DEGs) related to the clinical genotype of the KS disorder.** (**A**) Principal component (PC) analysis with top 10 000 expressing genes of KS, HM and HF fibroblasts (triangle) and corresponding hiPSC as well as female hESC line HS980 (circle). See also [Supplementary Tables SII](#sup5){ref-type="supplementary-material"}. (**B**) Downregulated and upregulated DEGs comparing KS with HM fibroblast and KS with HM hiPSCs. *P* \< 0.05 and fold change ≥1.5. See also [Supplementary Tables SII](#sup5){ref-type="supplementary-material"} and [SIII](#sup6){ref-type="supplementary-material"}. (**C**) Fold change of enriched GO terms of KS disorder-related terms for upregulated DEGs of KS fibroblasts, and downregulated DEGs of KS iPSCs, FDR \<0.01. See also [Supplementary Tables SIV](#sup7){ref-type="supplementary-material"}--[SVI](#sup9){ref-type="supplementary-material"}. (**D**) Heatmap of gene expression levels associated with fertility-related GO terms in HM and KS fibroblasts and MH and KS hiPSCs. See also [Supplementary Tables SV](#sup8){ref-type="supplementary-material"} and [SVII](#sup10){ref-type="supplementary-material"}.](dez134f2){#f2}

![**X chromosome inactivation (XCI) analysis of KS fibroblasts and hiPSCs indicates different XCI states.** (**A**) Gene expression level of XCI marker, *XIST*, relative to female fibroblasts (f-HF1). Mean expression of three biological replicates with ±SD; N.D. means no detection. (**B**) Distribution of *XIST* cloud expression in each cell line based on RNA FISH: one cloud (red), no cloud (white), or two clouds (yellow). Total count from three independent experiments, with \>193 cells counted per cell line. (**C**) Upper panel shows representative images of RNA fluorescence *in situ* hybridization (FISH) with one (red square) or two (yellow square) *XIST* clouds in HF (f-HF1) and KS (f-KS1 and f-KS2) fibroblasts. HM fibroblasts (f-HD1) were used as negative control showing no clouds (white square). Lower panel shows DNA FISH for X chromosome (green) and Y chromosome (red) for upper panel cells. DAPI (gray) was used as counterstaining. Scale bar is equal to 50 μm. (**D**) Representative images of RNA FISH with one (red square) or no (white square) *XIST* (red) cloud in HF (ips-HF1 and HS980) and KS (ips-KS1 and ips-KS2) hPSCs. HM hiPSCs (ips-HM1) were used as negative control showing no *XIST* (red) clouds. Active transcription site of *ATRX* is shown in blue. DAPI (gray) was used as counterstaining. Scale bar is equal to 50 μm. (**E**) Immunostaining of hPSCs for silencing methylation mark, H3K27me3 (red), with positive accumulation mark (red square) or no staining (white square). DAPI (gray) was used as counterstaining. Scale bar is equal to 50 μm.](dez134f3){#f3}

![**Transcriptomics analysis of XCI state of KS fibroblasts and hiPSC confirms the XaXe and XaXi state of KS hiPSCs.** (**A**) Total X chromosome expression (sum of FPKM values for X-linked genes) for HM, KS and HF fibroblasts and hiPSCs, and HS980. Significant compared to HM fibroblasts (f-HM-1 and f-HM2), HM hiPSCs (ips-HM1 and ips-HM2), KS fibroblasts (f-KS1 and f-KS2), and ips-KS2. Box-and-whisker plots representing the median value with 50% of all data falling within the box. The \`whiskers\' extend to the fifth and 95^th^ percentiles, *P* \< 0.05. (**B**) Total autosomal expression (sum of FPKM values for autosomal genes) for HM, KS and HF fibroblasts and hiPSCs, and HS980. Box-and-whisker plots representing the median value with 50% of all data falling within the box. The \`whiskers\' extend to the fifth and 95^th^ percentiles. (**C**) Number of transcripts showing mono-allelic or bi-allelic expression in KS and HF hPSCs. Results combined from three biological replicates. (**D**) Reported XCI status of bi-allelic transcripts (**E**) and mono-allelic transcripts in KS and HF hPSCs. See also [Supplementary Figure SII](#sup2){ref-type="supplementary-material"} and [Supplementary Table SVIII](#sup1){ref-type="supplementary-material"}.](dez134f4){#f4}

![**Upregulation of X-linked genes in ips-KS2 related to nervous system development, synaptic transmission, and metabolic processes.** (**A**) Chromosomal distribution of upregulated DEGs comparing either ips-KS1 or ips-KS2 with HM hiPSCs. See also [Supplementary Table SIX](#sup12){ref-type="supplementary-material"}. (**B**) Expression of X-linked genes showing up-regulated expression in ips-KS2 compared to HM hiPSC. Mean expression of three biological replicates with ±SD. Asterisk indicates upregulated genes that showed also bi-allelic expression in ips-KS2. See also [Supplementary Tables SVIII and SIX](#sup12){ref-type="supplementary-material"}.](dez134f5){#f5}

Looking at GO term enrichment of the 219 upregulated KS fibroblasts genes, multiple KS disorder-associated terms stood out ([Fig. 2C](#f2){ref-type="fig"}; [Supplementary Table SV](#sup8){ref-type="supplementary-material"}), whereas for 92 downregulated KS fibroblasts genes, only a few GO terms were enriched and mostly associated with vasculature development ([Supplementary Table SVI](#sup9){ref-type="supplementary-material"}). Interestingly, the 324 upregulated KS hiPSCs genes showed no GO term enrichment, whereas the 596 downregulated genes showed similar KS disorder-associated terms to the KS fibroblasts upregulated genes ([Fig. 2C](#f2){ref-type="fig"}; [Supplementary Table SVII](#sup10){ref-type="supplementary-material"}).

Enriched GO terms for DEGs of KS fibroblasts and hiPSCs included fertility-related terms, such as reproductive behavior, female sex differentiation, reproductive structure, ovulation cycle, and gonad development. The expression heatmap of genes associated with fertility-related GO terms for KS and HM fibroblasts as well as their hiPSC derivatives further demonstrates a dysregulation in gene expression levels, with KS fibroblasts showing upregulation and KS hiPSCs downregulation of fertility-related genes ([Fig. 2D](#f2){ref-type="fig"}; [Supplementary Tables SIV](#sup7){ref-type="supplementary-material"} and [SVI](#sup9){ref-type="supplementary-material"}). Comparison of DEGs between KS fibroblast and their respective hiPSC line revealed only fibroblast or hiPSC specific genes with no KS-specific relevance in GO terms of upregulated or downregulated genes (data not shown).

H3K27me3 staining and RNA FISH indicate different XCI states for the KS hiPSC lines {#sec18}
-----------------------------------------------------------------------------------

The expression level of *XIST* in KS fibroblasts (f-KS1 and f-KS2), KS, and female hiPSCs (ips-KS1, ips-KS2, and ips-HF1) was similar to HF fibroblasts (f-HF1) ([Fig. 3A](#f3){ref-type="fig"}), while no expression was observed for female hESCs (HS980). In alignment with a normal *in vivo* situation, HM fibroblasts (f-HM1 and f-HM2) and their hiPSCs derivatives (ips-HM1 and ips-HM2) showed no expression of *XIST*. Immunofluorescence staining for H3K27me3, a repressive chromatin marker that accumulates on the Xi, as well as RNA FISH for *XIST*, which coats the Xi, and *ATRX*, an X-linked gene that has one active transcription site for XaXi cells and two for XaXa cells, showed the presence of one *XIST* cloud in \>90% of cells for KS fibroblasts and HF fibroblasts ([Fig. 3B and C](#f3){ref-type="fig"}; [Supplementary Table SVIII](#sup1){ref-type="supplementary-material"}). No clouds were observed for HM fibroblasts. A small percentage of HF and KS fibroblasts showed expression of two *XIST* clouds ([Fig. 3B and C](#f3){ref-type="fig"}; [Supplementary Table SVIII](#sup1){ref-type="supplementary-material"}), which were all confirmed to be tetraploid cells upon DNA FISH analysis of the same cells ([Fig. 3C](#f3){ref-type="fig"}).

The XCI analysis of hPSCs showed more variability; KS hiPSC lines (ips-KS1 and ips-KS2) and female hPSC lines (ips-HF1 and HS980) consisted of two cell populations, showing either one or no H3K27me3 accumulation ([Fig. 3E](#f3){ref-type="fig"}) as well as one or no *XIST* cloud ([Fig. 3B and D](#f3){ref-type="fig"}; [Supplementary Table SVIII](#sup1){ref-type="supplementary-material"}). However, all hPSC lines displayed only mono-allelic *ATRX* transcription site ([Fig. 3D](#f3){ref-type="fig"}; [Supplementary Table SVIII](#sup1){ref-type="supplementary-material"}). Both HM hiPSC derivatives showed no H3K27me3 accumulation ([Fig. 3E](#f3){ref-type="fig"}) as well as no *XIST* cloud ([Fig. 3B and D](#f3){ref-type="fig"}; [Supplementary Table SVIII](#sup1){ref-type="supplementary-material"}) and one *ATRX* transcription site ([Fig. 3D](#f3){ref-type="fig"}; [Supplementary Table SVIII](#sup1){ref-type="supplementary-material"}).

Transcriptomics analysis shows erosion of XCI in one of the KS hiPSC lines {#sec19}
--------------------------------------------------------------------------

Transcriptomics data showed similar levels of the sum of total X chromosome expression in KS and HF fibroblasts and ips-KS2 compared to HM fibroblasts and hiPSCs ([Fig. 4A](#f4){ref-type="fig"}). On the contrary, the sum of total X chromosome expression was significantly increased for ips-KS1, ips-HF1, and HS980 ([Fig. 4A](#f4){ref-type="fig"}). As a control, the sum of autosomal expression showed similar levels among all fibroblasts as well as similar levels amongst all hPSCs ([Fig. 4B](#f4){ref-type="fig"}).

To investigate whether the X chromosome linked genes had mono- or bi-allelic expression in hPSCs, SNP variation from the RNA sequencing data against a reference genome were analyzed. In order to exclude false positive transcripts, we analyzed the HM fibroblasts and their hiPSC derivatives and observed a total of 12 unique transcripts that appeared as bi-allelic in one or more HM cell line ([Supplementary Fig. S3A](#sup3){ref-type="supplementary-material"}; [Supplementary Table SIX](#sup12){ref-type="supplementary-material"}), from which seven have a known Y homologue ([Supplementary Fig. S3B](#sup3){ref-type="supplementary-material"}; [Supplementary Table SIX](#sup12){ref-type="supplementary-material"}). We found that the majority of the X-linked transcripts in ips-KS2 had mono-allelic expression ([Fig. 4C](#f4){ref-type="fig"}; [Supplementary Table SIX](#sup12){ref-type="supplementary-material"}), and most of the bi-allelic transcripts were known XCI escapees ([Fig. 4D](#f4){ref-type="fig"}; [Supplementary Table SIX](#sup12){ref-type="supplementary-material"}). On the contrary, a high percentage of bi-allelic transcripts was observed for ips-KS1, ips-HF1, and HS980 ([Fig. 4C](#f4){ref-type="fig"}; [Supplementary Table SIX](#sup12){ref-type="supplementary-material"}), including many known XCI inactive genes ([Fig. 4D](#f4){ref-type="fig"}; [Supplementary Table SIX](#sup12){ref-type="supplementary-material"}). As expected, the majority of mono-allelic transcripts of ips-KS1, ips-KS2, ips-HF1, and HS980 belong to known XCI inactive genes ([Fig. 4E](#f4){ref-type="fig"}; [Supplementary Table SIX](#sup12){ref-type="supplementary-material"}).

Unlike hPSCs, fibroblasts are not clonally derived and therefore in the case of random XCI, both X chromosomes should be equally expressed in a cell population analysis. f-KS2 and f-HF1 cell lines showed SNP variation in \>82% of transcripts, indicating random XCI ([Fig. S2C](#sup2){ref-type="supplementary-material"}; [Supplementary Table SIX](#sup12){ref-type="supplementary-material"}). However, the f-KS1 cell line showed SNP variation for only 24% of transcripts, suggesting a skewed XCI ([Fig. S2C](#sup2){ref-type="supplementary-material"}; [Supplementary Table SIX](#sup12){ref-type="supplementary-material"}). In addition, the majority of the transcripts that did show SNP variation are known XCI escaping genes, further supporting skewed XCI in f-KS1 ([Supplementary Table SIX](#sup12){ref-type="supplementary-material"}).

The XCI analysis showed that ips-KS1 had a XaXe state, a known abnormal XCI state commonly observed in female hPSCs, whereas ips-KS2 had normal XCI supporting its potential relevance in KS disease, especially for X-linked genes. Therefore, we performed DEG analysis by comparing ips-KS1 and ips-KS2 individually with HM hiPSCs. We observed 111 upregulated genes for ips-KS2 of which 24 were X-linked genes ([Fig. 5A](#f5){ref-type="fig"}; [Supplementary Table SX](#sup13){ref-type="supplementary-material"}). In contrast, we observed 123 upregulated X-linked genes for ips-KS1, but a similar number of upregulated autosomal genes (68 ips-KS1 and 87 ips-KS2) ([Fig. 5A](#f5){ref-type="fig"}). GO analysis for downregulated genes in ips-KS2 (265) showed enrichment for terms that were mostly shared with an analysis using both ips-KS1 and ips-KS2 lines ([Supplementary Table SVII](#sup10){ref-type="supplementary-material"} and [SX](#sup13){ref-type="supplementary-material"}), suggesting that XCI status affects mostly the X-linked genes. From the 24 upregulated X-linked genes in ips-KS2, 3 were also showing bi-allelic expression: *A-kinase anchoring protein 17A* (*AKAP17A*), *glycogenin 2* (*GYG2*), *haloacid dehalogenase-like hydrolase domain-containing protein 1* (*HDHD1*) ([Fig. 5B](#f5){ref-type="fig"}; [Supplementary Table SIX](#sup12){ref-type="supplementary-material"}), and a substantial number of the genes are involved in nervous system development (*doublecortin* (*DCX*), *neuroligin 3* (*NLGN3*), *neuroligin 4 X-Linked* (*NLGN4X*), *proteolipid protein 1* (*PLP1*), and *nucleosome assembly protein 1 like 3* (*NAP1L3*)) as well as synaptic transmission (*gamma-aminobutyric acid type a receptor alpha3 subunit* (*GABRA3*)) ([Fig. 5B](#f5){ref-type="fig"}).

Discussion {#sec20}
==========

The infrequency of KS diagnosis is related to the diverse phenotypes associated with the condition that, at least in part, are caused by the number of supernumerary X chromosomes, the skewedness of XCI, as well as the genes escaping XCI. Since XCI escapee genes vary between individuals and even within different tissue of the same individual, the analysis of a variety of tissue types is needed for a better understanding of KS pathogenesis. Nevertheless, most molecular studies involving KS patients use whole blood, being easily accessible samples, for analysis ([@ref11]; [@ref48]; [@ref3]). However, in view of the fact that KS patients suffer from infertility, cognitive dysfunction, metabolic disruption, disruption in bone density, and cardiovascular complications ([@ref4]; [@ref15]), KS-derived hiPSCs provide a useful alternative to study early developmental defects of the KS disorder, as they can be differentiated into any cell type of the body.

Despite previous efforts in the generation of KS-derived hiPSCs from single patients, XCI analysis was either not performed ([@ref37]) or based solely on the H3K27me3 staining pattern and *XIST* expression levels, yet aberrant gene expression of X-linked genes was reported ([@ref21]) without consideration of the various XCI states that hPSC exhibit in culture ([@ref28]). In the present study, we focused on the derivation of hiPSCs from two azoospermic KS patients combined with detailed analysis of their XCI state. As LN521 has been shown to homogenize the stemness expression of hPSCs during culture ([@ref1]), LN521 was utilized as substrate to minimize variation in stemness states between the derived hiPSC lines while further allowing rapid expansion as monolayer cultures using an easy single-cell passaging method without the need of Rho kinase inhibitor ([@ref32]).

Using integration-free episomal plasmids ([@ref27]) together with NutriStem medium and LN521 as a substrate we were able to efficiently derive two KS, two HM and one HF hiPSC lines, each from different donors, with a high reprograming efficiency (0.52%) compared to previous studies using the same episomal plasmids with laminin-511 E8 fragments (0.077%) ([@ref26]) or LN521 in combination with polycistronic lentiviral vectors (0.3%) ([@ref20]).

Recent studies exploring the relation of KS transcription patterns to the clinical picture of KS have demonstrated a high association of DEGs between KS and HM controls toward phenotypic features such as waist circumference, metabolic syndrome, insulin resistance, verbal cognition, cardiac complications, and infertility ([@ref11]; [@ref48]; [@ref3]). Similarly, DEGs between KS and HM controls in our study showed disorder-related dysregulation in KS fibroblast and their hiPSC derivatives. As infertility is strongly associated with KS patients, we could observe dysregulation in fertility-related genes in KS fibroblasts and even more in KS hiPSC. Although it is possible to obtain spermatozoa from testicular sperm extractions for a few KS patients, the majority have suffered from germ cell loss upon diagnosis in adulthood. Therefore, approaches such as *in vitro* testicular somatic or germ cell differentiation from patient-derived hiPSCs could facilitate a better understanding of the germ cell loss mechanisms and potentially facilitate parenthood for those Sertoli-cell-only patients. Nevertheless, successful differentiation of hiPSCs into gametes and subsequently resulting in live birth have only been achieved in animal models to date, while differentiation to primordial germ cell up to spermatogonia stage has shown low efficiency in humans ([@ref5]; [@ref13]; [@ref36]).

In addition, the clinical picture of KS patients having cardiovascular problems, decreased bone density, and cognitive dysfunctions was reflected in enriched GO terms related to cardiovascular development, ossification, and brain development for both KS fibroblast and hiPSCs. Interestingly, the genes linked to these GO terms were upregulated in KS fibroblasts but downregulated in KS hiPSCs, reflecting a cell type-specific response. Furthermore, we observed additional enriched GO terms that were specific for either KS fibroblasts or hiPSCs. KS fibroblasts showed enrichment in GO terms for mammary gland epithelium development and prostate gland morphogenesis, possibly correlating with female phenotypic features such as gynecomastia as well as fertility related issues that KS patients suffer from. KS hiPSCs, however, showed enrichment in GO terms for response to corticosterone and estradiol, which are involved in metabolism and fertility and possibly impacting KS as early as during fetal development. Nevertheless, comparing KS fibroblasts to their respective hiPSC derivate revealed mostly fibroblast or hiPSC specific DEGs. Upon removal of genes common to comparisons of HM fibroblast with their hiPSC derivates, no KS specific GO terms could be observed, suggesting that a KS genotype may not have an effect on hiPSCs reprogramming.

Exploring the XCI status of KS fibroblasts we were able to observe similar expression levels of *XIST* and *XIST* cloud distribution relative to normal female fibroblasts, confirming XCI in KS fibroblasts. Although we could observe a small percentage of KS and HF fibroblasts showing two *XIST* clouds, we could confirm those cells as being tetraploid, tending to spontaneously occur as an artifact in fibroblast cultures ([@ref25]; [@ref35]). In addition, transcriptional analysis revealed evidence for skewed XCI of one KS fibroblast line (f-KS1) as only 24% of transcripts showed SNP variation (compared to \>82% in f-KS2 and f-HF1), and the majority of the transcripts were known XCI escaping genes. Skewed XCI has high prevalence in KS patients compared to females and is speculated to contribute to the range of mental deficiencies and phenotypic variation ([@ref12]).

Recent studies have shown that although female hPSC lines initially express one Xa and one Xi, the XCI maintenance during culture can be unstable resulting in cells with XCI (XaXi) with or without *XIST* coating or XCI with erosion of silencing (XaXe) ([@ref43]). In agreement, the female hPSCs in our study, ips-HF1 and HS980, had mostly XaXe status displayed by the loss of H3K27me3 marks and *XIST* clouds, while still showing only one active transcription site for *ATRX,* which is known to resist XCI erosion ([@ref43]). In addition, these cell lines displayed high X chromosomal expression and a high degree of bi-allelic transcripts, mostly classified as common XCI inactive genes. One KS hiPSC line, ips-KS1, showed similar evidence for XaXe, while the other line, ips-KS2, displayed normal XaXi status with H3K27me3 accumulation, *XIST* clouds, mono-allelic *ATRX*, a lower level of X chromosomal expression, and a low level of bi-allelic transcripts (being the XCI escaping genes *AKAP17A*, *HDHD1*, *GYG2*, and *taxilin gamma* (*TXLNG*)), or non-coding transcripts with unknown status (*PIR-FIGF readthrough* (*PIR-FIGF*) and *CD99 molecule pseudogene 1* (*CD99P1*)).

Since X chromosomal expression is thought to directly influence the KS phenotype, we looked specifically for X-linked DEGs and analyzed ips-KS1 and ips-KS2 separately due their different XCI states. Confirming the XaXe state of ips-KS1, we found 123 upregulated X-linked genes, whereas ips-KS2 with the XaXi state had only 24 upregulated X-linked genes. Since XaXe is an aberrant XCI state common to hPSCs and may not represent KS correctly, we focused on the ips-KS2 line. From the 24 upregulated X-linked genes, 6 were found to be upregulated for KS in other studies: *XIST* ([@ref44]; [@ref21]; [@ref3]; [@ref47]), *AKAP17A* ([@ref3]; [@ref47]), *SLC25A6* ([@ref48]; [@ref3]), *HDHD1* ([@ref48]), *NLGN4X* ([@ref47]), *PLCXD1* ([@ref3]), and *XIST* and *HDHD1* were also upregulated in KS fibroblasts, highlighting the importance of these genes for future studies. In addition, many of the upregulated genes were related to nervous system development (*DCX* ([@ref31]; [@ref2]), *NLGN3*, *NLGN4X* ([@ref6]), *PLP1*, *GABRA3*, and *NAP1L3* ([@ref7])) underlining the biological relevance of KS hiPSCs with normal XCI, even in the undifferentiated state. Nevertheless, further studies with *in vitro* differentiation of KS hiPSCs will be needed for a more detailed analysis of KS-related defects, for example for neuronal or germ cell development. In addition, conversion of KS hiPSCs into a naive pluripotency state could provide new insights for early developmental defects caused by supernumerary X chromosomes, as female naive hPSCs have the XaXa status similar to early human pre-implantation embryos.

Conclusion {#sec21}
==========

In conclusion, our results demonstrate that KS-derived hiPSCs show similar XCI behavior to female hPSCs in culture and show biological relevance to KS genotype-related clinical features associated with gonadal function and fertility. In addition, our results highlight the importance of XCI analysis for KS hiPSCs when studying dysregulation of X-linked genes associated with KS owing to the possibility of various XCI states in culture.
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